AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rotaspas M 40mg/250mg Tablet

Prescription Icon
Prescription Required

Marketer

Biological E Ltd

Salt Composition

Drotaverine (40mg) + Mefenamic Acid (250mg)

Overview Rotaspas M 40mg/250mg Tablet

Abdominal pain relief is provided by the combined medication Rotaspas M 40mg/250mg tablets. This formulation eases abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing chemical signals. Rotaspas M 40mg/250mg tablets should be ingested with food, following your physician's prescribed dosage and duration. Treatment length depends on your individual response and condition. Premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common, usually transient side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, appetite loss, thirst, and heartburn. Report any concerns about side effects immediately to your doctor. Dizziness and drowsiness may occur; avoid driving or activities requiring concentration until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Inform your doctor of pregnancy, pregnancy plans, breastfeeding, or existing kidney or liver conditions prior to commencing treatment to ensure appropriate dosage.

Primary Ingredients of Rotaspas M 40mg/250mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Rotaspas M 40mg/250mg Tablet

Managing abdominal discomfort

Major Benefits of Rotaspas M 40mg/250mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Rotaspas M 40 mg/250 mg Tablet should be administered with a meal.

Common Side effects of Rotaspas M 40mg/250mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Dryness in mouth
  • Heartburn
  • Vertigo
  • Insomnia (difficulty in sleeping)
  • Hypotension (low blood pressure)
  • Fast heart rate
  • Sweating
  • Constipation
  • Increased liver enzymes
  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count (lymphocytes)
  • Low blood platelets
  • Purpura
  • Agranulocytosis (deficiency of granulocytes in the blood)
  • Breathlessness
  • Ringing in ear
  • Abdominal pain
  • Flatulence
  • Indigestion
  • Stomach inflammation
  • Confusion
  • Depression

How to use Rotaspas M 40mg/250mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Rotaspas M 40 mg/250 mg tablets with a meal.

How Rotaspas M 40mg/250mg Tablet works:

Abdominal pain and cramping find relief in Rotaspas M 40 mg/250 mg Tablets, a dual-action formulation combining Drotaverine and Mefenamic Acid. Drotaverine, an antispasmodic, targets and alleviates smooth muscle contractions in the abdomen. Simultaneously, Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Rotaspas M 40 mg/250 mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Rotaspas M 40 mg/250 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Rotaspas M 40 mg/250 mg Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving ability may be impaired by Rotaspas M 40 mg/250 mg Tablets, a potential side effect of this medication due to the possibility of vertigo.

KidneyKidneyCAUTION

Patients with kidney impairment should use Rotaspas M 40 mg/250 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Rotaspas M 40 mg/250 mg tablets are contraindicated in those with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Rotaspas M 40 mg/250 mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Rotaspas M 40mg/250mg Tablet :

Should you forget to take a Rotaspas M 40 mg/250 mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Rotaspas M 40mg/250mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Digestive system

FAQs on Rotaspas M 40mg/250mg Tablet

Rotaspas M 40 mg/250 mg tablets contain drotaverine and mefenamic acid, which work together to alleviate abdominal discomfort. Drotaverine targets abdominal smooth muscle spasms, while mefenamic acid inhibits the production of pain- and inflammation-inducing chemical mediators.
Rotaspas M 40 mg/250 mg tablets are generally well-tolerated by individuals experiencing abdominal pain. Nevertheless, some users may encounter typical adverse reactions such as nausea, vomiting, indigestion, diarrhea, decreased appetite, dry mouth, fatigue, drowsiness, or less frequent or infrequent side effects. Promptly contact your physician should any medication-related issue persist.
The 40 mg/250 mg Rotaspas M tablet is typically prescribed for short-term use, ceasing once pain subsides. Nevertheless, continue taking the medication if your doctor recommends ongoing treatment.
Nausea and vomiting are potential side effects of Rotaspas M 40 mg/250 mg Tablets. Consuming the medication with milk, food, or antacids may mitigate nausea. Persistent vomiting should prompt increased fluid intake, achieved through small, frequent sips of water or other fluids. Fatty or fried foods should be avoided while taking this medicine. Consult your physician if vomiting continues or dehydration symptoms, such as decreased urination and dark, strong-smelling urine, appear. Do not use other medications without your doctor's approval.
Dry mouth is a potential side effect of Rotaspas M 40 mg/250 mg Tablets. To alleviate this, increase your water intake; frequent small drinks throughout the day and a bedside glass overnight are recommended. Lip balm can help with dry lips. A diet low in spicy, salty, and acidic foods, such as citrus fruits, is also advisable.
Avoid exceeding the prescribed dosage of Rotaspas M 40 mg/250 mg tablets; higher doses raise the likelihood of adverse reactions. Should your pain worsen or fail to respond to the recommended dosage, seek medical advice.
Retain this medication within its original, sealed container or packaging. Follow the storage directions provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Rotaspas M 40mg/250mg Tab...
50
MRP 61
17% off